PFE 250110 24.50P (PFE250110P24500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PFE250110P24500

Watchlist

0.01
0.000.00%

15min DelayClose Jan 10 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Pfizer Options Spot-On: On January 23rd, 459.46K Contracts Were Traded, With 2.69 Million Open Interest
Moomoo News16:30 ET
Wall Street Today: S&P 500 Closes at Record, Trump Keeps Appearing on TV
Kevin Travers16:07 ET
Unusual Options Activity: BE, FLR and Others Attract Market Bets, BE V/OI Ratio Reaches 711.2
Moomoo News13:30 ET
Live Stock News: Market Waiting to See if the President Says Something Exciting Today
Kevin Travers11:08 ET
Here's Why Pfizer (PFE) Is a Strong Value Stock
Yahoo FinanceJan 23 09:40 ET
Jefferies Keeps Their Buy Rating on Pfizer (PFE)
TipRanksJan 23 08:26 ET · Ratings

Comments

105750561

1 hour ago

CatchandRun

8 hours ago

$Pfizer (PFE.US)$ lets go for high dividen and keep for long term!

70790164

8 hours ago

$Pfizer (PFE.US)$ trump is gonna reveal pfizer scam soon, should i sell ?

Deep Sea

8 hours ago

$Pfizer (PFE.US)$
Tomorrow is the XD.

10xStockPicks

9 hours ago

Today 3 Analysts Place BUY Ratings On This $2 Stock $7,$9 & $16 Which Is An Acquisition Target by BIG Pharma

$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...